Remus Pharmaceuticals Limited (NSE:REMUS)

India · Delayed Price · Currency is INR

856.25

+11.80 (1.40%)

Oct 7, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Pharmaceutical	8.54B	6.20B	2.13B	451.32M	247.17M
Total	8.54B	6.20B	2.13B	451.32M	247.17M

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
India	3.25B	2.76B	718.60M	10.73M	15.55M
Latin America and The Caribbean	878.40M	677.60M	552.50M	-	-
Europe	470.00M	405.00M	75.80M	-	-
Middle East	41.80M	13.70M	18.30M	-	-
Africa	4.20M	23.60M	-	-	-
Asia	2.44B	1.10B	154.40M	-	-
North America	1.44B	1.22B	609.80M	-	-
Oceania	14.40M	-	-	-	-
Export	-	-	-	439.54M	231.62M
Total	8.54B	6.20B	2.13B	450.27M	247.17M